 AbCellera Biologics Inc NASDAQ:ABCL Q3 2022 Earnings Conference Call November 8, 2022 5:00 PM ET Company Participants Tryn Stimart - Chief Legal and Compliance Officer Carl Hansen - Chairman, Chief Executive Officer and President Andrew Booth - Chief Financial Officer Conference Call Participants Do Kim - Piper Sandler Gaurav Goparaju - Berenberg Capital Markets Stephen Willey - Stifel Financial Corp. Gary Nachman - BMO Capital Markets Antonia Borovina - Bloom Burton Operator Good afternoon. And welcome to AbCelleras Third Quarter 2022 Business Update Conference Call. 